Company intelligence / Profile preview

Xylem

Rye Brook, New York, United Statesxylem.com ↗

Ownership: Public · XYL
Employees: ~12500
Development stage: Commercial

Overview

Xylem is a global leader in water technology, providing advanced analytical instruments and solutions for laboratory, industrial, environmental, pharmaceutical manufacturing, bioprocessing, clinical research labs, and quality control. Its products are essential for measuring parameters such as pH, conductivity, dissolved oxygen, glucose/lactate levels in blood or cell culture media; supporting pharmaceutical production quality assurance; ensuring compliance with pharmacopeia standards; and enabling bioprocess monitoring.

Industry: Metabolite Diagnostics

Partnerships

No major pharma/biotech drug development partnerships reported. Collaborates broadly with academic labs and industry on instrumentation supply.

Financials

Market cap: $25.4B
Total revenue: $2.3B
Enterprise value: $27.2B

Beyond the preview

Go deeper on Xylem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xylem.

Explore the full profile